BNP (Brain Natriuretic Peptide) — Indexed Studies

Proteomic effects of short-term liraglutide vs. placebo in a blinded crossover RCT: Implications for efficacy, safety, and comparison with semaglutide.

Stefanakis K, Gutierrez de Piñeres V, Veeragandham P et al.

Pilot study of canakinumab (Ilaris) in steroid naïve children with Duchenne muscular dystrophy demonstrates safety and exploratory changes in potential serum protein response biomarkers.

Spurney CF, Chong J, Gordish-Dressman H et al.

GDF8 and activin A are the key negative regulators of muscle mass in postmenopausal females: a randomized phase I trial.

Gonzalez Trotter D, Donahue S, Wynne C et al.

Impact of Disease Severity and Disease-Modifying Therapies on Myostatin Levels in SMA Patients.

Mackels L, Mariot V, Buscemi L et al.

Effects of Lenvatinib on Skeletal Muscle Volume and Cardiac Function in Patients with Hepatocellular Carcinoma.

Nagai H, Amanuma M, Mukozu T et al.

Myostatin Overexpression and Smad Pathway in Detrusor Derived from Pediatric Patients with End-Stage Lower Urinary Tract Dysfunction.

Salemi S, Schori LJ, Gerwinn T et al.

Effect of Combined Antiretroviral Therapy on the Levels of Selected Parameters Reflecting Metabolic and Inflammatory Disturbances in HIV-Infected Patients.

Jurkowska K, Szymańska B, Knysz B et al.

A Randomized Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of the Novel Myostatin Inhibitor Apitegromab (SRK-015): A Potential Treatment for Spinal Muscular Atrophy.

Barrett D, Bilic S, Chyung Y et al.

Randomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophy.

Wagner KR, Abdel-Hamid HZ, Mah JK et al.

Fortetropin inhibits disuse muscle atrophy in dogs after tibial plateau leveling osteotomy.

White DA, Harkin KR, Roush JK et al.

Effects of dapagliflozin on the serum levels of fibroblast growth factor 21 and myokines and muscle mass in Japanese patients with type 2 diabetes: A randomized, controlled trial.

Yamakage H, Tanaka M, Inoue T et al.

Comparing Model Performance in Characterizing the PK/PD of the Anti-Myostatin Antibody Domagrozumab.

Tiwari A, Bhattacharya I, Chan PLS et al.

Fat, muscle, and anti-obesity medications in cardiovascular disease prevention.

Khan MS, Dawood MH, Handelsman Y et al.

Epigenetic inhibition of class I histone deacetylases by MS-275 attenuates diabetic skeletal muscle atrophy via Akt/ARK5-FoxO and myostatin-Smad signaling.

Son Y, Byeon HE, Choi SE et al.

Novel myostatin inhibition by Acacia farnesiana: A network pharmacology workflow decoding its multi-target mechanism in sarcopenic obesity.

Zhang W, Akhtar F, Sun J

Potent and durable gene modulation in heart and muscle with chemically defined lipophilic siRNAs.

Fakih HH, Lochmann C, Gagnon R et al.

Emerging Role of Myostatin Inhibitors in the Management of Glucagon-Like Peptide-1-Associated Sarcopenia and Metabolic Disorders.

Baik J, Lee YS

Dynamic Anchoring of Peptides to the Extracellular Matrix Enabled by Boronic Acid.

Mergenthaler M, Asumendi EM, Höpfel AI et al.

Pharmacological inhibition of myostatin effectively ameliorates osteolytic lesions in syngeneic and xenograft breast cancer mouse models.

Reinhardt J, Dankbar B, Geers F et al.

Bimagrumab: Novel Medical Therapy for Inclusion Body Myositis, Sarcopenia, and Medication-Induced Lean Body Mass Loss.

Kaiser M, Parikh MA, Turitto G et al.

Silencing Myostatin Using In Vivo Self-Assembled siRNA Protects Against Cancer- and Dexamethasone-Induced Muscle Atrophy.

Yin X, Anwar A, Chen J et al.

Myostatin antisense administration prevents sepsis-induced muscle atrophy and weakness in male mice.

Nakanishi N, Maeta K, Ono Y et al.

Smad2/3 Signaling Mediates the Atrophic Response in Vocal Fold Myoblasts In Vitro.

Yoshimatsu M, Nakamura R, Bing R et al.

Molecular mechanism of Activin receptor inhibition by DLK1.

Antfolk D, Ming Q, Manturova A et al.

A myostatin inhibitory antibody combined with insulin, partially rescues the musculoskeletal phenotype of female insulin-deficient diabetic mice.

Bunn RC, Adatorwovor R, Ray PD et al.

Apocynin Mitigates Diabetic Muscle Atrophy by Lowering Muscle Triglycerides and Oxidative Stress.

Sánchez-Duarte S, Sánchez-Duarte E, Sánchez-Briones LA et al.

Exploring the Myostatin Activation Pathway: A Promising Target for Treating Muscle Atrophy.

Quintanilha DB, Dos Santos HF

Combined detection of inhibitors of the activin receptor signaling pathways (IASPs) by means of LC-HRMS/MS for human doping control.

Sakellariou P, Walpurgis K, Thomas A et al.

Construction of contractile human iPSC-derived skeletal muscle tissues on 96-well scale microdevices.

Nakamura S, Kamei Y, Matsushima A et al.

A Combination of Resveratrol and Quercetin Prevents Sarcopenic Obesity: Its Role as a Signaling Inhibitor of Myostatin/ActRIIA and ActRIIB/Smad and as an Enhancer of Insulin Actions.

Cano-Martínez A, Méndez-Castro JA, García-Vázquez VE et al.

GDF8 and activin A blockade protects against GLP-1-induced muscle loss while enhancing fat loss in obese male mice and non-human primates.

Mastaitis JW, Gomez D, Raya JG et al.

Maternal Health and Safety Outcomes of Prenatal Myostatin Inhibition in Osteogenesis Imperfecta Mice.

Crawford TK, Lafaver BN, Oestreich AK et al.

Inhibiting Myostatin Expression by the Antisense Oligonucleotides Improves Muscle Wasting in a Chronic Kidney Disease Mouse Model.

Akhter A, Md Sheikh A, Yoshino J et al.

Endurance exercise remodels skeletal muscle by suppressing Ythdf1-mediated myostatin expression.

Huang X, Xu C, Zhang J et al.

Effect of blocking transforming growth factor-β/Activin-Myostatin signaling on the expression of ecdysteroid metabolism and responsive genes in the crustacean molting gland (Y-organ).

Benrabaa SAM, Mykles DL

The Effects of Laxogenin and 5-Alpha-hydroxy-laxogenin on Myotube Formation and Maturation During Cultured Meat Production.

Lim JH, Ahmad SS, Hwang YC et al.

Intermittent breaking of isolation may ameliorate decrease in physical activity caused by isolation.

Uchida A, Nakagawa K, Yoshimi K et al.

Simultaneous detection of myostatin-targeting monoclonal antibodies in dried blood spots and plasma using liquid chromatography-tandem mass spectrometry with field asymmetric ion mobility spectrometry.

Lee HJ, Hwang J, Seo Y et al.

A molecular pathway for cancer cachexia-induced muscle atrophy revealed at single-nucleus resolution.

Zhang Y, Dos Santos M, Huang H et al.

Inflammatory Cytokine-Induced Muscle Atrophy and Weakness Can Be Ameliorated by an Inhibition of TGF-β-Activated Kinase-1.

Kanai M, Ganbaatar B, Endo I et al.

Unveiling the Potential of Nelumbo nucifera-Derived Liensinine to Target The Myostatin Protein and to Counteract Muscle Atrophy.

Zheng Y, Yu Y, Feng J et al.

Licochalcone A and B enhance muscle proliferation and differentiation by regulating Myostatin.

Ahmad K, Lee EJ, Ali S et al.

Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism.

Nunn E, Jaiswal N, Gavin M et al.

The effect of modification of DNA interference on myostatin gene expression in mice.

Riasi M, Mozaffari-Jovin S, Javadmanesh A

Growth differentiation factor myostatin regulates epithelial-mesenchymal transition genes and enhances invasion by increasing serine protease inhibitors E1 and E2 in human trophoblast cells.

AbdelHafez FF, Klausen C, Zhu H et al.

Plum modulates Myoglianin and regulates synaptic function in D. melanogaster.

Sahota VK, Stone A, Woodling NS et al.

Effects of Tofacitinib on Muscle Remodeling in Experimental Rheumatoid Sarcopenia.

Bermejo-Álvarez I, Pérez-Baos S, Gratal P et al.

A novel splice variant of the human MSTN gene encodes a myostatin-specific myostatin inhibitor.

Maeta K, Farea M, Nishio H et al.

Inhibitor Design Strategy for Myostatin: Dynamics and Interaction Networks Define the Affinity and Release Mechanisms of the Inhibited Complexes.

Nagy-Fazekas D, Fazekas Z, Taricska N et al.

Synergistically Acting on Myostatin and Agrin Pathways Increases Neuromuscular Junction Stability and Endurance in Old Mice.

Schellino R, Boido M, Vrijbloed JW et al.